AI assistant
Anteris Technologies Global Corp. — Capital/Financing Update 2026
Jan 20, 2026
33869_rns_2026-01-20_8b428a6a-bc46-4c00-b799-c789eb665b62.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
ANTERIS TECHNOLOGIES GLOBAL CORP.
Announcement Type
New announcement
Date of this announcement
21/1/2026
The Proposed issue is:
A placement or other type of issue
Total number of +securities proposed to be issued for a placement or other type of issue
| Maximum Number of | ||
|---|---|---|
| ASX +security code | +Security description | +securities to be issued |
| AVRAAM | COMMON STOCK | 55,652,173 |
| Proposed +issue date | ||
| 23/1/2026 |
Refer to next page for full details of the announcement
Appendix 3B - Proposed issue of securities
1 / 6
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 1 - Entity and announcement details
1.1 Name of +Entity
ANTERIS TECHNOLOGIES GLOBAL CORP.
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
1.2 Registered Number Type
ARBN
Registration Number
677960235
1.3 ASX issuer code
AVR
1.4 The announcement is
New announcement
1.5 Date of this announcement
21/1/2026
1.6 The Proposed issue is:
A placement or other type of issue
Appendix 3B - Proposed issue of securities
2 / 6
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 7 - Details of proposed placement or other issue
Part 7A - Conditions
7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other type of issue can proceed on an unconditional basis? No
Part 7B - Issue details
Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? Existing class
Will the proposed issue of this +security include an offer of attaching +securities? No
Details of +securities proposed to be issued
ASX +security code and description
AVRAAM : COMMON STOCK
Number of +securities proposed to be issued
40,000,000
Offer price details
Are the +securities proposed to be issued being issued for a cash consideration? Yes
In what currency is the cash What is the issue price per consideration being paid? +security? USS - US Dollar (Same day) USS 5.75000
AUD equivalent to issue price amount per +security
8.540000
FX rate (in format AUD 1.00 / primary FX rate (in format AUD rate/primary currency rate): currency rate) Primary Currency rate USS 0.67310000 AUD 1.00
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Appendix 3B - Proposed issue of securities
3 / 6
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Is the proposed security a 'New Will the proposed issue of this class' (+securities in a class that is +security include an offer of not yet quoted or recorded by ASX) attaching +securities? or an 'Existing class' (additional No securities in a class that is already quoted or recorded by ASX)? Existing class
Details of +securities proposed to be issued
ASX +security code and description
AVRAAM : COMMON STOCK
Number of +securities proposed to be issued
15,652,173
Offer price details
Are the +securities proposed to be issued being issued for a cash consideration? Yes
In what currency is the cash What is the issue price per consideration being paid? +security? USD - US Dollar USD 5.75000
AUD equivalent to issue price amount per +security
8.540000
FX rate (in format AUD 1.00 / primary FX rate (in format AUD rate/primary currency rate): currency rate) Primary Currency rate USD 0.67310000 AUD 1.00
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Part 7C - Timetable
7C.1 Proposed +issue date
23/1/2026
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? No
7D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15%
Appendix 3B - Proposed issue of securities
4 / 6
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
placement capacity under listing rule 7.1?
Yes
7D.1b ( i ) How many +securities are proposed to be issued without security holder approval using the entity's 15% placement capacity under listing rule 7.1?
The ASX granted and stockholders approved a waiver from ASX Listing Rule 7.1 for a period of three years from 29 September 2025 to permit the Company to issue new securities without obtaining security holder approval under ASX Listing Rule 7.1.
7D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No
7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No
7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules? No
7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the proposed issue?
Yes
7E.1a Who is the lead manager/broker?
There are two placements incorporated into the Appendix 3B:
(i) US$230M public offering including the underwriters' 30-day option ('Public Offering') - Barclays Capital Inc. ('Barclays'), Wells Fargo Securities ('Wells Fargo'), LLC and Cantor Fitzgerald & Co. ('Cantor') are acting as joint book-running managers for the Offering. Barrenjoey Markets Pty Limited ('Barrenjoey') is acting as financial advisor in connection with the Offering to investors in Asia-Pacific and certain other jurisdictions outside of the United States and Canada. (ii) US$90M stock purchase agreement with Medtronic plc (through a wholly owned subsidiary) ('Private Placement') - Wells Fargo is acting as placement agent in connection with the Private Placement.
7E.1b What fee, commission or other consideration is payable to them for acting as lead manager/broker?
(i) Barclays, Wells Fargo and Cantor will be entitled to underwriting discounts and commissions equal to 5.1% of the price to the public of the securities sold in the Public Offering. Barrenjoey will be entitled to a fee equal to 0.9% of the price to the public of the securities sold in the Public Offering.
(ii) Wells Fargo will receive a cash fee of 6% of the funds raised under the Private Placement, plus 3% of any future investments made by the investor for a period of 2 years.
7E.2 Is the proposed issue to be underwritten?
Yes
7E.2a Who are the underwriter(s)?
Barclays, Wells Fargo and Cantor are underwriting the Public Offering. The Private Placement is not underwritten.
7E.2b What is the extent of the underwriting (ie the amount or proportion of the proposed issue that is underwritten)?
The Public Offering is fully underwritten. The Private Placement is not underwritten.
7E.2c What fee, commission or other consideration is payable to them for acting as underwriter(s)?
Refer to 7E.1b
7E.2d Please provide a summary of the significant events that could lead to the underwriting being terminated.
The underwriting agreement may be terminated upon the occurrence of certain events that are so material and adverse to the company as to make it impracticable or inadvisable to proceed with the Public Offering, in the reasonable judgment of the underwriters.
7E.3 Is a party referred to in listing rule 10.11 underwriting or sub-underwriting the proposed issue? No
Appendix 3B - Proposed issue of securities
5 / 6
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue Nil.
Part 7F - Further Information
7F.01 The purpose(s) for which the entity is issuing the securities
Refer to the ASX announcement released earlier today for further information.
7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds? No
7F.2 Any other information the entity wishes to provide about the proposed issue
Refer to the preliminary prospectus supplement and ASX announcements released earlier today for further information.
Appendix 3B - Proposed issue of securities
6 / 6